Procoagulant inhibitory properties of paclitaxel poliglumex

by John Nemunaitis, Neil Senzer, Barry Cooper, et al
Published 2010-12-01

KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex.

by Donald D Rao, Xiuquan Luo, Zhaohui Wang, Christopher M Jay, Francis C Brunicardi, William Maltese, Luisa Manning, Neil Senzer, John Nemunaitis
Published 2018-01-01

Notch1 Activation Up-Regulates Pancreatic and Duodenal Homeobox-1

by Min Li, F. Charles Brunicardi, William E. Fisher, David Dawson, Neil Senzer, James Wu, John Nemunaitis, Shi-He Liu, Guisheng Zhou, Juehua Yu
Published 2013-07-01

Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance

by Johnathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi
Published 2020-11-01

Corrigendum to “Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance” [Gynecol. Oncol. Rep. 34 (202...

by Jonathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi
Published 2021-05-01

PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform.

by Shi-He Liu, Donald D Rao, John Nemunaitis, Neil Senzer, Guisheng Zhou, David Dawson, Marie-Claude Gingras, Zhaohui Wang, Richard Gibbs, Michael Norman, Nancy S Templeton, Francesco J Demayo, Bert O'Malley, Robbi Sanchez, William E Fisher, F Charles Brunicardi
Published 2012-01-01